Major constituent of St. John’s wort, a herbal remedy widely used for the treatment of depression. Inhibits the reuptake of neurotransmitters in synapses. Activator of the pregnane X receptor (PXR), which serves as a key regulator of CYP3A4 transcription, a member of the cytochrome (CYP) P450 enzyme system. Specifically activates TRPC6 channels. Represents an interesting lead-structure for the development of antidepressants. Displays several other biological properties of potential pharmacological interest, including antibacterial, anti-inflammational, antitumoral and anti-angiogenic effects.
Induces apoptosis in various cancer cells.
Product Specification
| Purity Detail: | Contains <3% adhyperforin. |
| |
| Formula: | C35H51O4 . C12H24N |
| |
| MW: | 535.8 . 182.3 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | White to off-white powder. |
| |
| CAS: | 11079-53-1 (non-salt form) |
| |
| Source/Host: | Isolated from St. John's wort (Hypericum perforatum). |
| |
| Solubility: | Soluble in DMSO, methanol or 100% ethanol. |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Keep under inert gas. Protect from light. |
| |
Please mouse over
Product Literature References
Hyperforin a key constituent of St. John’s wort specifically activates TRPC6 channels: K. Leuner, et al.; FASEB J.
21, 4101 (2007),
Abstract;
Hyperforin, a new lead compound against the progression of cancer and leukemia?: C. Quiney, et al.; Leukemia
20, 1519 (2006), (Review),
Abstract;
Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent: M. Gartner, et al.; Chembiochem
6, 171 (2005),
Abstract;
Effect of St. John's wort on free radical production: E.J. Hunt, et al.; Life Sci.
69, 181 (2001),
Abstract;
Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology: P.J. Nathan; J. Psychopharmacol.
15, 47 (2001), (Review),
Abstract;
St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties: J. Barnes, et al.; J. Pharm. Pharmacol.
53, 583 (2001), (Review),
Abstract;
St John's wort: Prozac from the plant kingdom: G. Di Carlo, et al.; TIPS
22, 292 (2001), (Review),
Abstract;
Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression: R.S. Obach; J. Pharmacol. Exp. Ther.
294, 88 (2000),
Abstract;
St John's wort, a herbal antidepressant, activates the steroid X receptor: J.M. Wentworth, et al.; J. Endocrinol.
166, R11 (2000),
Abstract;
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor: L.B. Moore, et al.; PNAS
97, 7500 (2000),
Abstract;
Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria: C.M. Schempp, et al.; Lancet
353, 2129 (1999),
Abstract;
Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat: S. Chatterjee, et al.; Life Sci.
65, 2395 (1999),
Abstract;
Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1: A. Singer, et al.; J. Pharmacol. Exp. Ther.
290, 1363 (1999),
Abstract;
Hyperforin as a possible antidepressant component of hypericum extracts: S.S. Chatterjee, et al.; Life Sci.
63, 499 (1998),
Abstract;